- Home
- DNTH vs OMI Comparison
DNTH vs OMI Comparison
Compare DNTH & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- OMI
- Stock Information
- Founded
- DNTH 2015
- OMI 1882
- Country
- DNTH United States
- OMI United States
- Employees
- DNTH N/A
- OMI N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- OMI Medical Specialities
- Sector
- DNTH Health Care
- OMI Health Care
- Exchange
- DNTH Nasdaq
- OMI Nasdaq
- Market Cap
- DNTH 568.6M
- OMI 545.4M
- IPO Year
- DNTH N/A
- OMI N/A
- Fundamental
- Price
- DNTH $18.85
- OMI $9.21
- Analyst Decision
- DNTH Strong Buy
- OMI Hold
- Analyst Count
- DNTH 8
- OMI 6
- Target Price
- DNTH $53.00
- OMI $12.67
- AVG Volume (30 Days)
- DNTH 315.6K
- OMI 1.6M
- Earning Date
- DNTH 08-07-2025
- OMI 08-01-2025
- Dividend Yield
- DNTH N/A
- OMI N/A
- EPS Growth
- DNTH N/A
- OMI N/A
- EPS
- DNTH N/A
- OMI N/A
- Revenue
- DNTH $6,524,000.00
- OMI $10,720,251,000.00
- Revenue This Year
- DNTH N/A
- OMI $3.66
- Revenue Next Year
- DNTH N/A
- OMI $2.52
- P/E Ratio
- DNTH N/A
- OMI N/A
- Revenue Growth
- DNTH 102.36
- OMI 2.84
- 52 Week Low
- DNTH $13.37
- OMI $6.07
- 52 Week High
- DNTH $32.27
- OMI $16.98
- Technical
- Relative Strength Index (RSI)
- DNTH 54.07
- OMI 68.91
- Support Level
- DNTH $17.27
- OMI $7.03
- Resistance Level
- DNTH $19.46
- OMI $9.55
- Average True Range (ATR)
- DNTH 1.07
- OMI 0.44
- MACD
- DNTH 0.15
- OMI 0.18
- Stochastic Oscillator
- DNTH 76.74
- OMI 86.51
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.